Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for PONV in pediatric patients
NCT00828295Phase 3Completed
- Sponsor
- Helsinn
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Helsinn. Started Aug 2008; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00828295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828295.